These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1329882

  • 1. Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
    Smit EF, Piers DA, Postmus PE.
    Eur J Cancer; 1992; 28A(12):1965-7. PubMed ID: 1329882
    [Abstract] [Full Text] [Related]

  • 2. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Comella P, Scoppa G, Daponte A, Musetta G, Anania C, Maiorino A, Curcio C, Casaretti R, Comella G.
    Cancer; 1994 Oct 01; 74(7):1874-81. PubMed ID: 8082093
    [Abstract] [Full Text] [Related]

  • 3. Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.
    Pignon T, Ruggieri S, Boutin C, Gouvernet J, Irisson M, Juin P, Astoul P.
    Cancer; 1999 May 15; 85(10):2144-50. PubMed ID: 10326692
    [Abstract] [Full Text] [Related]

  • 4. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N, Fukuoka M, Kudoh S, Matsui K, Kusunoki Y, Takada M, Nakagawa K, Hirashima T, Tsukada H, Yana T.
    J Clin Oncol; 1994 Sep 15; 12(9):1833-41. PubMed ID: 7521905
    [Abstract] [Full Text] [Related]

  • 5. Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
    Johnson DH, DeVore R, Greco FA, Walls J, Thomas M, Hande KR, Hainsworth JD.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 2):50-6. PubMed ID: 1329223
    [Abstract] [Full Text] [Related]

  • 6. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
    Huisman C, Biesma B, Postmus PE, Giaccone G, Schramel FM, Smit EF.
    Br J Cancer; 2001 Nov 16; 85(10):1456-61. PubMed ID: 11720428
    [Abstract] [Full Text] [Related]

  • 7. Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer.
    Macchiarini P, Chella A, Riva A, Mengozzi G, Silvano G, Solfanelli S, Angeletti CA.
    Am J Clin Oncol; 1990 Dec 16; 13(6):495-500. PubMed ID: 2173392
    [Abstract] [Full Text] [Related]

  • 8. A phase II study of high dose epirubicin in unresectable non small cell lung cancer.
    Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE.
    Br J Cancer; 1992 Mar 16; 65(3):405-8. PubMed ID: 1313691
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD, Gray JR, Stroup SL, Kalman LA, Patten JE, Hopkins LG, Thomas M, Greco FA.
    J Clin Oncol; 1997 Dec 16; 15(12):3464-70. PubMed ID: 9396399
    [Abstract] [Full Text] [Related]

  • 10. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).
    Phernambucq EC, Biesma B, Smit EF, Paul MA, vd Tol A, Schramel FM, Bolhuis RJ, Postmus PE.
    Br J Cancer; 2006 Aug 21; 95(4):470-4. PubMed ID: 16909132
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer.
    Gridelli C, De Placido S, Pepe R, Incoronato P, Airoma G, Rossi A, Palazzolo G, Bianco AR.
    Eur J Cancer; 1993 Aug 21; 29A(12):1729-31. PubMed ID: 7691117
    [Abstract] [Full Text] [Related]

  • 12. Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer.
    Rosell R, Carles J, Abad A, Jimeno JM, Moreno I, Barnadas A, Ribelles N, Haboubi N.
    Invest New Drugs; 1992 Jul 21; 10(2):123-8. PubMed ID: 1323550
    [Abstract] [Full Text] [Related]

  • 13. VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer.
    Altavilla G, Adamo V, Alafaci E, Buemi B, Caristi N, Condemi G, Toscano G.
    Tumori; 1989 Apr 30; 75(2):168-70. PubMed ID: 2545020
    [Abstract] [Full Text] [Related]

  • 14. Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer.
    Gridelli C, Rossi A, Incoronato P, Bruni GS, Scognamiglio F, Ruffolo P, Rinaldi L, Bianco AR.
    Cancer Chemother Pharmacol; 1996 Apr 30; 37(6):613-5. PubMed ID: 8612318
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy consisting of epirubicin, cisplatin, and etoposide followed by irradiation in stage III non-small cell lung cancer and chemotherapy alone in stage IV non-small cell lung cancer.
    Wils J, Utama I, Smeets J.
    Oncology; 1988 Apr 30; 45(6):413-6. PubMed ID: 2847098
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun 30; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 17. A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC).
    Martoni A, Guaraldi M, Casadio M, Busutti L, Pannuti F.
    Ann Oncol; 1992 Dec 30; 3(10):864-6. PubMed ID: 1337467
    [Abstract] [Full Text] [Related]

  • 18. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb 30; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 19. Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    Pfeiffer P, Sørensen P, Rose C.
    Eur J Cancer; 1995 Feb 30; 31A(1):64-9. PubMed ID: 7695981
    [Abstract] [Full Text] [Related]

  • 20. 5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.
    Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M.
    Cancer; 1991 Sep 01; 68(5):944-7. PubMed ID: 1655218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.